References
- Dawson, T. M. and Dawson, V. L. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822. https://doi.org/10.1126/science.1087753
- Eriksen, J. L., Wszolek, Z. and Petrucelli, L. (2005) Molecular pathogenesis of Parkinson disease. Arch. Neurol. 62, 353-357. https://doi.org/10.1001/archneur.62.3.353
- Morales-Garcia, J. A., Redondo, M., Alonso-Gil, S., Gil, C., Perex, C., Martinez, A., Santos, A. and Perez-Castillo, A. (2011) Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease. PLoS ONE 6, e17240. https://doi.org/10.1371/journal.pone.0017240
- Dauer, W. and Przedborski, S. (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889-909. https://doi.org/10.1016/S0896-6273(03)00568-3
- Warner, T. T. and Schapira, A. H. (2003) Genetic and environmental factors in the cause of Parkinson's disease. Ann. Neurol. 53, S16-S25. https://doi.org/10.1002/ana.10487
- Eriksen, J. L., Przedborski, S. and Petrucelli, L. (2005) Gene dosage and pathogenesis of Parkinson's disease. Trends Mol. Med. 11, 91-96. https://doi.org/10.1016/j.molmed.2005.01.001
- Tasaki, Y., Omura, T., Yamada, T., Ohkubo, T., Suno, M., Iida, S., Sakaguchi, T., Asari, M., Shimizu, K. and Matsubara, K. (2010) Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells. Brain Res. 1344, 25-33. https://doi.org/10.1016/j.brainres.2010.04.085
- Subbareddy, M., Sudharsana, R. A., Soumya, P., Ted, P., Kazimierz, W., Anne, Z., Mehdi, E., Kamala, D. M., Emilia, W. and Marek, L. (2007) Cell survival, cell death and cell cycle pathway are interconnected: Implications for cancer therapy. Drug Resist. Updates 10, 13-29. https://doi.org/10.1016/j.drup.2007.01.003
- Grant, S. and Roberts, J. D. (2003) The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy. Drug Resist. Updates 6, 15-26. https://doi.org/10.1016/S1368-7646(02)00141-3
- Schwartz, G. K. and Shah, M. A. (2005) Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol. 23, 9408-9421. https://doi.org/10.1200/JCO.2005.01.5594
- Eduardo, T. C., Maria, E. S., Julieta, M. C., Mariela, C. M., Abel, L. C., Pablo, F. S. and Maria, F. O. (2007) INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 59, 419-426. https://doi.org/10.1080/15216540701488358
- Wadia, J. S. and Dowdy, S. F. (2002) Protein transduction technology. Curr. Opin. Biotechnol. 13, 52-56. https://doi.org/10.1016/S0958-1669(02)00284-7
- Morris, M. C., Depollier, J., Mery, J., Heitz, F. and Divita, G. (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19, 1173-1176. https://doi.org/10.1038/nbt1201-1173
- Eum, W. S., Kim, D. W., Hwang, I. K., Yoo, K. Y., Kang, T. C., Jang, S. H., Choi, H. S., Choi, S. H., Kim, Y. H., Kim, S. Y., Kwon, H. Y., Kang, J. H., Kwon, O. S., Cho, S. W., Lee, K. S., Park, J., Won, M. H. and Choi, S. Y. (2004) In vivo protein transduction: Biologically active intact PEP-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. Free Radic. Biol. Med. 37, 1656-1669. https://doi.org/10.1016/j.freeradbiomed.2004.07.028
- Choi, H. S., An, J. J., Kim, S. Y., Lee, S. H., Kim, D. W., Yoo, K. Y., Won, M. H., Kang, T. C., Kwon, H. J., Kang, J. H., Cho, S. W., Kwon, O. S., Park, J., Eum, W. S. and Choi, S. Y. (2006) PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model. Free Radic. Biol. Med. 41, 1058-1068. https://doi.org/10.1016/j.freeradbiomed.2006.06.006
- Ahn, E. H., Kim, D. W., Kang, H. W., Shin, M. J., Won, M. H., Kim, J., Kim, D. J., Kwon, O. S., Kang, T. C., Han, K. H., Park, J., Eum, W. S. and Choi, S. Y. (2010) Transduced PEP-1-ribosomal protein S3 (rpS3) ameliorates 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Toxicol. 276, 192-197. https://doi.org/10.1016/j.tox.2010.08.004
- An, J. J., Lee, Y. P., Kim, S. Y., Lee, S. H., Lee, M. J., Jeong, M. S., Kim, D. W., Jang, S. H., Yoo, K. Y., Won, M. H., Kang, T. C., Kwon, O. S., Cho, S. W., Lee, K. S., Park, J., Eum, W. S. and Choi, S. Y. (2008) Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult. FEBS J. 275, 1296-1308. https://doi.org/10.1111/j.1742-4658.2008.06291.x
- Kim, M. J., Kim, D. W., Yoo, K. Y., Sohn, E. J., Jeong, H. J., Kang, H. W., Shin, M. J., Ahn, J. J., Kwon, S. W., Kim, Y. N., Won, M. H., Cho, S. W., Park, J., Eum, W. S. and Choi, S. Y. (2010) Protective effects of transduced PEP-1-Frataxin protein on oxidative stress-induced neuronal cell death. J. Neurol. Sci. 298, 64-69. https://doi.org/10.1016/j.jns.2010.08.016
- Lee, S. H., Kim, D. W., Back, S. S., Hwang, H. S., Park, E. Y., Kang, T. C., Kwon, O. S., Park, J. H., Cho, S. W., Han, K. H., Park, J., Eum, W. S. and Choi, S. Y. (2011) Transduced Tat-annexin protein suppresses inflammation-associated gene expression in lipopolysaccharide (LPS)-stimulated Raw 264.7 cells. BMB Rep. 44, 484-489. https://doi.org/10.5483/BMBRep.2011.44.7.484
- Shin, M. J., Lee, Y. P., Kim, D. W., An, J. J., Jang, S. H., Cho, S. M., Sheen, S. H., Lee, H. R., Kweon, H. Y., Kang, S. W., Lee, K. G., Park, J., Eum, W. S., Cho, Y. J. and Choi, S. Y. (2010) Transduced PEP-1-AMPK inhibits the LPS-induced expression of COX-2 and iNOS in Raw 264.7 cells. BMB Rep. 43, 40-45. https://doi.org/10.5483/BMBRep.2010.43.1.040
- Egleton, R. D. and Davis, T. P. (1997) Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 18, 1431-1439. https://doi.org/10.1016/S0196-9781(97)00242-8
- Dietz, G. P. (2010) Cell-penetrating peptide technology to delivery chaperones and associated factors in diseases and basic research. Curr. Pharm. Biotechnol. 11, 167-174. https://doi.org/10.2174/138920110790909731
-
Kim, S. Y., Kim, M. Y., Mo, J. S., Park, J. W. and Park, H. S. (2007) SAG protects human neuroblastoma SH-SY5Y cells against 1-methyl-4-phenylpyridinium ion (
$MPP^+$ )-induced cytotoxicity via the downregulation of ROS generation and JNK signaling. Neurosci. Lett. 413, 132-136. https://doi.org/10.1016/j.neulet.2006.11.074 - Chung, Y. C., Ko, H. W., Bok, E., Park, E. S., Huh, S. H., Nam, J. H. and Jin, B. K. (2010) The role of neuroinflammation on the pathogenesis of Parkinson's disease. BMB Rep. 43, 225-232. https://doi.org/10.5483/BMBRep.2010.43.4.225
- Brouckaert, G., Kalai, M., Saelens, X. and Vandenabeels, P. (2005) Apoptotic pathways and their regulation. In: Los, M., Gibson. S. B. (eds.), Apoptotic pathway as target for novel therapies in cancer and other diseases. Springer Academic Press, New York, USA.
- Finkel, E. (2001) The mitochondrian: is it central to apoptosis? Science 292, 624-626. https://doi.org/10.1126/science.292.5517.624
- Maddika, S., Mendoza, F. J., Fauff, K., Zamzow, C. R., Paranjothy, T. and Los, M. (2006) Cancer-selective therapy of the further: apoptin and its mechanism of action. Cancer Biol. Ther. 5, 10-19. https://doi.org/10.4161/cbt.5.1.2400
- Deng, X., Gao, F. and May JR, W. S. (2003) Bcl-2 retards G1/S cell cycle transition by regulating intracellular ROS. Blood 102, 3179-3185. https://doi.org/10.1182/blood-2003-04-1027
- Araki, T., Mikami, T., Tanji, H., Matsubara, M., Imai, Y., Mizugaki, M. and Itoyama, Y. (2001). Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse. Eur. J. Pharm. Sci. 12, 231-238. https://doi.org/10.1016/S0928-0987(00)00170-6
- Bradford, M. A. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254. https://doi.org/10.1016/0003-2697(76)90527-3
Cited by
- Tat-Fused Recombinant Human SAG Prevents Dopaminergic Neurodegeneration in a MPTP-Induced Parkinson’s Disease Model vol.37, pp.3, 2014, https://doi.org/10.14348/molcells.2014.2314
- Neuroprotective effect of PEP-1-peroxiredoxin2 on CA1 regions in the hippocampus against ischemic insult vol.1840, pp.7, 2014, https://doi.org/10.1016/j.bbagen.2014.03.003
- Down-regulation of MAPK/NF-κB signaling underlies anti-inflammatory response induced by transduced PEP-1-Prx2 proteins in LPS-induced Raw 264.7 and TPA-induced mouse ear edema model vol.23, pp.2, 2014, https://doi.org/10.1016/j.intimp.2014.09.008
- Tat-glyoxalase protein inhibits against ischemic neuronal cell damage and ameliorates ischemic injury vol.67, 2014, https://doi.org/10.1016/j.freeradbiomed.2013.10.815
- PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson's disease mouse model vol.47, pp.10, 2014, https://doi.org/10.5483/BMBRep.2014.47.10.286
- Effect of respiratory syncytial virus on the growth of hepatocellular carcinoma cell-lines vol.48, pp.10, 2015, https://doi.org/10.5483/BMBRep.2015.48.10.268
- PEP-1-PEA-15 protects against toxin-induced neuronal damage in a mouse model of Parkinson's disease vol.1840, pp.6, 2014, https://doi.org/10.1016/j.bbagen.2014.01.004
- Phosphorylation of the N-terminal domain of p48 Ebp1 by CDK2 is required for tumorigenic function of p48 vol.54, pp.11, 2015, https://doi.org/10.1002/mc.22203
- PEP-1–ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model vol.55, 2013, https://doi.org/10.1016/j.freeradbiomed.2012.11.008
- The efficacy of chimeric vaccines constructed with PEP-1 and Ii-Key linking to a hybrid epitope from heterologous viruses vol.43, pp.5, 2015, https://doi.org/10.1016/j.biologicals.2015.06.005
- PEP-1-PON1 Protein Regulates Inflammatory Response in Raw 264.7 Macrophages and Ameliorates Inflammation in a TPA-Induced Animal Model vol.9, pp.1, 2014, https://doi.org/10.1371/journal.pone.0086034
- PEP-1–SIRT2 inhibits inflammatory response and oxidative stress-induced cell death via expression of antioxidant enzymes in murine macrophages vol.63, 2013, https://doi.org/10.1016/j.freeradbiomed.2013.06.005
- Tat-biliverdin reductase A inhibits inflammatory response by regulation of MAPK and NF-κB pathways in Raw 264.7 cells and edema mouse model vol.63, pp.2, 2015, https://doi.org/10.1016/j.molimm.2014.09.003
- Anti-inflammatory mechanisms of N-adamantyl-4-methylthiazol-2-amine in lipopolysaccharide-stimulated BV-2 microglial cells vol.22, pp.1, 2014, https://doi.org/10.1016/j.intimp.2014.06.022